Compare NICM & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NICM | SXTC |
|---|---|---|
| Founded | 1980 | 2005 |
| Country | Canada | China |
| Employees | 25 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 92.9M |
| IPO Year | N/A | 2017 |
| Metric | NICM | SXTC |
|---|---|---|
| Price | $5.06 | $2.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.6K | ★ 13.6M |
| Earning Date | 11-27-2026 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $355.99 | N/A |
| Revenue Next Year | $161.43 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.71 | $0.03 |
| 52 Week High | $7.00 | $9.59 |
| Indicator | NICM | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 59.19 |
| Support Level | $4.71 | $1.71 |
| Resistance Level | $5.68 | $4.23 |
| Average True Range (ATR) | 0.25 | 0.38 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 20.59 | 69.93 |
Nicola Mining Inc is a junior exploration and custom milling company that is engaged in the business of identification, acquisition, and exploration of mineral property interests, together with custom milling partnerships at its Merritt Mill. The company holds interests in various claims at the following properties: the Treasure Mountain Property, New Craigmont Property, and Dominion Creek Property. Its portfolio of producing assets and development projects is mainly composed of copper, gold, and silver properties spread across British Columbia, Canada.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.